ナトリウムオキシバートの溶解 軟食品と代替液体再構成用
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
PubMedで要約を見る
まとめ
この要約は機械生成です。ナトリウムオキシベート (ON-SXB) は,様々な柔らかい食品や液体媒介物と溶解した状態を維持します. 投与の柔軟性により ナルコレプシーの管理が改善され 患者さんの治療の順守が改善されます
科学分野
- 薬理学と医薬品
- 神経学
- 薬物投与システム
背景
- ナルコレプシーは,日中の過剰な眠気 (EDS) とカタプレクシーを引き起こす慢性神経疾患です.
- ナトリウムオキシベート (ON- SXB) は,解消後に経口投与される,ナルコレプシーの治療薬です.
- ON-SXBの溶解の理解は,患者のアデランスと効果的な治療に不可欠です.
研究 の 目的
- 柔らかい食品や代替液体媒介物と溶解した時のON-SXBの溶解プロフィールを評価する.
- これらの媒介体におけるON-SXBの溶解と水中の溶解を比較する.
- ON-SXBの代替溶解方法の有効性を決定する.
主な方法
- ON-SXB (4. 5gと9g) はレモンプーディング,バニラヨーグルト,リンゴソース,ラズベリーレモネード,フルーツパンチ,およびアルカリ水に溶けました.
- 溶解試験は15分,2時間,4時間後に実施した.
- 溶解率は,製品仕様の承認基準と比較した.
主要な成果
- 試験されたすべての柔らかい食品と液体容器は,4. 5gと9gの両方の時間点において,ON-SXB溶解の受容基準を満たした.
- 15分,2時間,4時間後の溶解率は,ON- SXBを水中に溶解したときに観測された値と一致した.
- 特定の平均溶解値は15分後に45%から51%, 2時間後に49%から51%, 4時間後に87%から97%であった.
結論
- 軟食 (レモンプーディング,ヨーグルト,リンゴソース) と液体媒介 (ラズベリーレモネード,フルーツパンチ,アルカリ水) は,ON-SXBの溶解に適した代替品です.
- これらの代替品は,薬の溶解特性を維持し,一貫した治療効果を保証します.
- ON-SXBの柔軟な投与方法を提供することで,患者のアデバーンスが向上し,全般的なナルコレプシーの管理が改善される可能性があります.
関連する概念動画
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
Medications can be administered through the enteral route using liquids, capsules, or tablets.
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...